ID   VRK1_HUMAN              Reviewed;         396 AA.
AC   Q99986; Q3SYL2;
DT   10-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   02-NOV-2010, entry version 97.
DE   RecName: Full=Serine/threonine-protein kinase VRK1;
DE            EC=2.7.11.1;
DE   AltName: Full=Vaccinia-related kinase 1;
GN   Name=VRK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Fetal liver;
RX   MEDLINE=98008921; PubMed=9344656; DOI=10.1006/geno.1997.4938;
RA   Nezu J., Oku A., Jones M.H., Shimane M.;
RT   "Identification of two novel human putative serine/threonine kinases,
RT   VRK1 and VRK2, with structural similarity to Vaccinia virus B1R
RT   kinase.";
RL   Genomics 45:327-331(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION, SUBCELLULAR LOCATION, AUTOPHOSPHORYLATION, AND MUTAGENESIS
RP   OF SER-14; THR-102; SER-125; SER-150; SER-158; SER-239; THR-305;
RP   THR-312; THR-355 AND THR-390.
RX   MEDLINE=20406546; PubMed=10951572; DOI=10.1038/sj.onc.1203709;
RA   Lopez-Borges S., Lazo P.A.;
RT   "The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-
RT   18 within the mdm-2 binding site of the p53 tumour suppressor
RT   protein.";
RL   Oncogene 19:3656-3664(2000).
RN   [4]
RP   AUTOPHOSPHORYLATION, AND ENZYME REGULATION.
RX   MEDLINE=21881264; PubMed=11883897; DOI=10.1006/abbi.2001.2746;
RA   Barcia R., Lopez-Borges S., Vega F.M., Lazo P.A.;
RT   "Kinetic properties of p53 phosphorylation by the human vaccinia-
RT   related kinase 1.";
RL   Arch. Biochem. Biophys. 399:1-5(2002).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [6]
RP   INVOLVEMENT IN PCH1.
RX   PubMed=19646678; DOI=10.1016/j.ajhg.2009.07.006;
RA   Renbaum P., Kellerman E., Jaron R., Geiger D., Segel R., Lee M.,
RA   King M.C., Levy-Lahad E.;
RT   "Spinal muscular atrophy with pontocerebellar hypoplasia is caused by
RT   a mutation in the VRK1 gene.";
RL   Am. J. Hum. Genet. 85:281-289(2009).
CC   -!- FUNCTION: Serine/threonine kinase that phosphorylates 'Thr-18' of
CC       p53/TP53 and may thereby prevent the interaction between p53/TP53
CC       and MDM2.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Active in presence of Mn(2+), Mg(2+) and
CC       Zn(2+), but is not functional with Ca(2+) or Cu(2+). Has a higher
CC       affinity for Mn(2+) than for Mg(2+).
CC   -!- INTERACTION:
CC       P15336:ATF2; NbExp=1; IntAct=EBI-1769146, EBI-1170906;
CC       P05412:JUN; NbExp=3; IntAct=EBI-1769146, EBI-852823;
CC       Q9H4B4:PLK3; NbExp=6; IntAct=EBI-1769146, EBI-751877;
CC       P62826:RAN; NbExp=4; IntAct=EBI-1769146, EBI-286642;
CC       P02340:Tp53 (xeno); NbExp=1; IntAct=EBI-1769146, EBI-474016;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Note=Dispersed throughout the cell
CC       but not located on mitotic spindle or chromatids during mitosis.
CC   -!- TISSUE SPECIFICITY: Widely expressed. Highly expressed in fetal
CC       liver, testis and thymus.
CC   -!- PTM: Autophosphorylated at various serine and threonine residues.
CC       Autophosphorylation does not impair its ability to phosphorylate
CC       p53/TP53.
CC   -!- DISEASE: Defects in VRK1 are the cause of pontocerebellar
CC       hypoplasia type 1 (PCH1) [MIM:607596]; also called pontocerebellar
CC       hypoplasia with infantile spinal muscular atrophy or
CC       pontocerebellar hypoplasia with anterior horn cell disease. PCH1
CC       is characterized by an abnormally small cerebellum and brainstem,
CC       central and peripheral motor dysfunction from birth, gliosis and
CC       anterior horn cell degeneration resembling infantile spinal
CC       muscular atrophy (SMA).
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CK1 Ser/Thr
CC       protein kinase family. VRK subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/VRK1ID43556ch14q32.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB000449; BAA19108.1; -; mRNA.
DR   EMBL; BC103761; AAI03762.1; -; mRNA.
DR   EMBL; BC112075; AAI12076.1; -; mRNA.
DR   EMBL; BC113510; AAI13511.1; -; mRNA.
DR   IPI; IPI00019640; -.
DR   RefSeq; NP_003375.1; -.
DR   UniGene; Hs.422662; -.
DR   PDB; 3OP5; X-ray; 2.40 A; A/B/C/D=3-364.
DR   PDBsum; 3OP5; -.
DR   ProteinModelPortal; Q99986; -.
DR   SMR; Q99986; 23-325.
DR   IntAct; Q99986; 49.
DR   STRING; Q99986; -.
DR   PhosphoSite; Q99986; -.
DR   PeptideAtlas; Q99986; -.
DR   PRIDE; Q99986; -.
DR   Ensembl; ENST00000216639; ENSP00000216639; ENSG00000100749.
DR   GeneID; 7443; -.
DR   KEGG; hsa:7443; -.
DR   UCSC; uc001yft.1; human.
DR   CTD; 7443; -.
DR   GeneCards; GC14P097263; -.
DR   H-InvDB; HIX0037640; -.
DR   HGNC; HGNC:12718; VRK1.
DR   HPA; HPA000660; -.
DR   HPA; HPA017929; -.
DR   MIM; 602168; gene.
DR   MIM; 607596; phenotype.
DR   Orphanet; 2254; Pontocerebellar hypoplasia type 1.
DR   PharmGKB; PA37330; -.
DR   eggNOG; prNOG16668; -.
DR   HOGENOM; HBG715700; -.
DR   HOVERGEN; HBG007532; -.
DR   InParanoid; Q99986; -.
DR   OMA; NKPGEIA; -.
DR   OrthoDB; EOG9ZCWQ7; -.
DR   PhylomeDB; Q99986; -.
DR   BRENDA; 2.7.11.1; 247.
DR   NextBio; 29150; -.
DR   ArrayExpress; Q99986; -.
DR   Bgee; Q99986; -.
DR   CleanEx; HS_VRK1; -.
DR   Genevestigator; Q99986; -.
DR   GermOnline; ENSG00000100749; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome; Kinase;
KW   Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    396       Serine/threonine-protein kinase VRK1.
FT                                /FTId=PRO_0000086803.
FT   DOMAIN       37    317       Protein kinase.
FT   NP_BIND      43     51       ATP (By similarity).
FT   ACT_SITE    177    177       Proton acceptor (By similarity).
FT   BINDING      71     71       ATP (By similarity).
FT   MOD_RES     355    355       Phosphothreonine; by autocatalysis.
FT   MUTAGEN      14     14       S->A: Does not abolish
FT                                autophosphorylation.
FT   MUTAGEN     102    102       T->A: Does not abolish
FT                                autophosphorylation.
FT   MUTAGEN     125    125       S->A: Does not abolish
FT                                autophosphorylation.
FT   MUTAGEN     150    150       S->A: Does not abolish
FT                                autophosphorylation.
FT   MUTAGEN     158    158       S->A: Does not abolish
FT                                autophosphorylation.
FT   MUTAGEN     239    239       S->A: Does not abolish
FT                                autophosphorylation.
FT   MUTAGEN     305    305       T->A: Does not abolish
FT                                autophosphorylation.
FT   MUTAGEN     312    312       T->A: Does not abolish
FT                                autophosphorylation.
FT   MUTAGEN     355    355       T->A: Does not abolish
FT                                autophosphorylation.
FT   MUTAGEN     390    390       T->A: Does not abolish
FT                                autophosphorylation.
SQ   SEQUENCE   396 AA;  45476 MW;  5640C624BF059949 CRC64;
     MPRVKAAQAG RQSSAKRHLA EQFAVGEIIT DMAKKEWKVG LPIGQGGFGC IYLADMNSSE
     SVGSDAPCVV KVEPSDNGPL FTELKFYQRA AKPEQIQKWI RTRKLKYLGV PKYWGSGLHD
     KNGKSYRFMI MDRFGSDLQK IYEANAKRFS RKTVLQLSLR ILDILEYIHE HEYVHGDIKA
     SNLLLNYKNP DQVYLVDYGL AYRYCPEGVH KEYKEDPKRC HDGTIEFTSI DAHNGVAPSR
     RGDLEILGYC MIQWLTGHLP WEDNLKDPKY VRDSKIRYRE NIASLMDKCF PEKNKPGEIA
     KYMETVKLLD YTEKPLYENL RDILLQGLKA IGSKDDGKLD LSVVENGGLK AKTITKKRKK
     EIEESKEPGV EDTEWSNTQT EEAIQTRSRT RKRVQK
//
